ZYUS Life Sciences Corporation
ZLSCF
$0.01
-$0.03-65.75%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -24.12M | -24.36M | -24.36M | -24.68M |
| Total Depreciation and Amortization | -- | 2.06M | 2.07M | 2.07M | 2.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 14.41M | 14.31M | 14.31M | 14.00M |
| Change in Net Operating Assets | -- | -1.36M | -281.60K | -281.60K | 224.80K |
| Cash from Operations | -- | -9.00M | -8.27M | -8.27M | -8.34M |
| Capital Expenditure | -- | -7.20K | -8.80K | -8.80K | -8.80K |
| Sale of Property, Plant, and Equipment | -- | 18.10K | 18.10K | 18.10K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.34M | 1.34M | 1.34M | 2.50M |
| Cash from Investing | -- | 1.35M | 1.35M | 1.35M | 2.49M |
| Total Debt Issued | -- | 11.04M | 8.96M | 8.96M | 7.45M |
| Total Debt Repaid | -- | -314.00K | -2.86M | -2.86M | -2.86M |
| Issuance of Common Stock | -- | 0.00 | 3.31M | 3.31M | 3.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 7.68M | 6.73M | 6.73M | 5.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 29.30K | -186.20K | -186.20K | -205.30K |